Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study. (atsiveria naujas langas)

Abdelrazik N, Fouda M

Šaltinis‎: Hematology 2007;12(6):533-41.

Kodas‎: PubMed 17852440

DOI‎: 10.1080/10245330701521572

https://www.ncbi.nlm.nih.gov/pubmed/17852440 (atsiveria naujas langas)

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial. (atsiveria naujas langas)

Cabanillas ME, Kantarjian H, Thomas DA, Mattiuzzi GN, Rytting ME, Bruera E, Xiao L, Bekele BN, Foudray MC, Cortes JE.

Šaltinis‎: Cancer 2012;118(3):848-55.

Kodas‎: PubMed 21751205

DOI‎: 10.1002/cncr.26341

https://www.ncbi.nlm.nih.gov/pubmed/21751205 (atsiveria naujas langas)

Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment. (atsiveria naujas langas)

Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A

Šaltinis‎: Pediatr Hematol Oncol 2008;25(6):509-21.

Kodas‎: PubMed 18728970

DOI‎: 10.1080/08880010802235132

https://www.ncbi.nlm.nih.gov/pubmed/18728970 (atsiveria naujas langas)

Recombinant human erythropoietin beta: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients. (atsiveria naujas langas)

Durmaz O, Demirkaya M, Sevinir B

Šaltinis‎: Pediatr Hematol Oncol 2011;28(6):461-8.

Kodas‎: PubMed 21707225

DOI‎: 10.3109/08880018.2011.570857

https://www.ncbi.nlm.nih.gov/pubmed/21707225 (atsiveria naujas langas)

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. (atsiveria naujas langas)

Engert A, Josting A, Haverkamp H, Villalobos M, Lohri A, Sökler M, Zijlstra J, Sturm I, Topp MS, Rank A, Zenz T, Vogelhuber M, Nogova L, Borchmann P, Fuchs M, Flechtner HH, Diehl V.

Šaltinis‎: J Clin Oncol 2010;28(13):2239-45.

Kodas‎: PubMed 20368566

DOI‎: 10.1200/JCO.2009.25.1835

https://www.ncbi.nlm.nih.gov/pubmed/20368566 (atsiveria naujas langas)

Treatment patterns and outcomes in management of solid cancer patients suffering from anemia in Penang hospital. (atsiveria naujas langas)

Hassan BA, Yusoff ZB

Šaltinis‎: Asian Pac J Cancer Prev 2011;12(6):1573-6.

Kodas‎: PubMed 22126501

https://www.ncbi.nlm.nih.gov/pubmed/22126501 (atsiveria naujas langas)

Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia. (atsiveria naujas langas)

Hernandez E, Ganly P, Charu V, Dibenedetto J, Tomita D, Lillie T, Taylor K; ARANESP 20030232 Study Group

Šaltinis‎: Curr Med Res Opin 2009;25(9):2109-20.

Kodas‎: PubMed 19601709

DOI‎: 10.1185/03007990903084164

https://www.ncbi.nlm.nih.gov/pubmed/19601709 (atsiveria naujas langas)

Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy. (atsiveria naujas langas)

Hinds PS, Hockenberry M, Feusner J, Hord JD, Rackoff W, Rozzouk BI

Šaltinis‎: J Support Oncol 2005;3(6 Suppl 4):10-1.

Kodas‎: PubMed 16355549

https://www.ncbi.nlm.nih.gov/pubmed/16355549 (atsiveria naujas langas)

The efficacy of recombinant human erythropoietin in treatment chemotherapy induced anemia in children diagnosed with a solid cancer. (atsiveria naujas langas)

Hiradfar A, Banihosseinian M

Šaltinis‎: Iran J Ped Hematol Oncol 2014;4(4):151-9.

Kodas‎: PubMed 25598955

https://www.ncbi.nlm.nih.gov/pubmed/25598955 (atsiveria naujas langas)

2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer. (atsiveria naujas langas)

Marec-Berard P, Chastagner P, Kassab-Chahmi D, Casadevall N, Marchal C, Misset JL, Ray-Coquard I.

Šaltinis‎: Pediatr Blood Cancer 2009;53(1):7-12.

Kodas‎: PubMed 19229970

DOI‎: 10.1002/pbc.21953

https://www.ncbi.nlm.nih.gov/pubmed/19229970 (atsiveria naujas langas)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (atsiveria naujas langas)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Šaltinis‎: Cancer 2013;119(1):107-14.

Kodas‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (atsiveria naujas langas)

Erythropoietic growth factors for children with cancer: a systematic review of the literature. (atsiveria naujas langas)

Mystakidou K, Potamianou A, Tsilika E

Šaltinis‎: Curr Med Res Opin 2007;23(11):2841-7.

Kodas‎: PubMed 17910805

DOI‎: 10.1185/030079907x242601

https://www.ncbi.nlm.nih.gov/pubmed/17910805 (atsiveria naujas langas)

Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. (atsiveria naujas langas)

Razzouk BI, Hord JD, Hockenberry M, Hinds PS, Feusner J, Williams D, Rackoff WR

Šaltinis‎: J Clin Oncol 2006;24(22):3583-9.

Kodas‎: PubMed 16877725

DOI‎: 10.1200/JCO.2005.03.4371

https://www.ncbi.nlm.nih.gov/pubmed/16877725 (atsiveria naujas langas)

The role of recombinant erythropoietin in childhood cancer. (atsiveria naujas langas)

Shankar AG

Šaltinis‎: Oncologist 2008;13(2):157-66.

Kodas‎: PubMed 18305061

DOI‎: 10.1634/theoncologist.2007-0126

https://www.ncbi.nlm.nih.gov/pubmed/18305061 (atsiveria naujas langas)

Efficacy and safety of iorEPOCIM for chemotherapy- or radiotherapy-induced anemia in pediatric cancer patients. (atsiveria naujas langas)

Vargas A, Mendoza I, Uranga R, González A, Martínez L, Caballero I, Piedra P, Saurez G, Verdecia M, Cabanas R

Šaltinis‎: MEDICC Rev 2010;12(3):27-31.

Kodas‎: PubMed 20697335

DOI‎: 10.37757/MR2010.V12.N3.7

https://www.ncbi.nlm.nih.gov/pubmed/20697335 (atsiveria naujas langas)

A single institutional experience: is epoetin alpha effective in anemic children with cancer? (atsiveria naujas langas)

Yilmaz D, Cetingül N, Kantar M, Oniz H, Kansoy S, Kavakli K

Šaltinis‎: Pediatr Hematol Oncol 2004;21(1):1-8.

Kodas‎: PubMed 14660300

https://www.ncbi.nlm.nih.gov/pubmed/14660300 (atsiveria naujas langas)

Single dose darbepoetin alfa is useful in reducing red cell transfusions in leukemic children receiving chemotherapy. (atsiveria naujas langas)

Zachariah M, Elshinawy M, Alrawas A, Bashir W, Elbeshlawi I, Tony S, Wali Y

Šaltinis‎: Pediatr Hematol Oncol 2014;31(5):442-7.

Kodas‎: PubMed 24088186

DOI‎: 10.3109/08880018.2013.824527

https://www.ncbi.nlm.nih.gov/pubmed/24088186 (atsiveria naujas langas)

Early epoetin alfa treatment in children with solid tumors. (atsiveria naujas langas)

Zoubek A, Kronberger M

Šaltinis‎: Med Pediatr Oncol 2002;39(4):459-62.

Kodas‎: PubMed 12203664

DOI‎: 10.1002/mpo.10186

https://www.ncbi.nlm.nih.gov/pubmed/12203664 (atsiveria naujas langas)

Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. (atsiveria naujas langas)

Crary SE, Hall K, Buchanan GR.

Šaltinis‎: Pediatr Blood Cancer 2011;56(4):615-9.

Kodas‎: PubMed 21298748

DOI‎: 10.1002/pbc.22930

https://www.ncbi.nlm.nih.gov/pubmed/21298748 (atsiveria naujas langas)

Intravenous iron sucrose for children with iron deficiency anemia. (atsiveria naujas langas)

Kaneva K, Chow E, Rosenfield CG, Kelly MJ

Šaltinis‎: J Pediatr Hematol Oncol 2017;39(5):e259-62.

Kodas‎: PubMed 28562517

DOI‎: 10.1097/MPH.0000000000000879

https://www.ncbi.nlm.nih.gov/pubmed/28562517 (atsiveria naujas langas)

Advances in Pediatric Intravenous Iron Therapy. (atsiveria naujas langas)

Mantadakis E.

Šaltinis‎: Pediatr Blood Cancer 2016;63(1):11-6.

Kodas‎: PubMed 26376214

DOI‎: 10.1002/pbc.25752

https://www.ncbi.nlm.nih.gov/pubmed/26376214 (atsiveria naujas langas)

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. (atsiveria naujas langas)

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Šaltinis‎: Cochrane Database Syst Rev 2016;(2):CD009624.

Kodas‎: PubMed 26845108

DOI‎: 10.1002/14651858.CD009624.pub2

https://www.ncbi.nlm.nih.gov/pubmed/26845108 (atsiveria naujas langas)

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. (atsiveria naujas langas)

Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S.

Šaltinis‎: J Clin Oncol 2008;26(10):1619-25.

Kodas‎: PubMed 18375891

DOI‎: 10.1200/JCO.2007.12.2051

https://www.ncbi.nlm.nih.gov/pubmed/18375891 (atsiveria naujas langas)

Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. (atsiveria naujas langas)

Plummer ES, Crary SE, McCavit TL, Buchanan GR

Šaltinis‎: Pediatr Blood Cancer 2013;60(11):1747-52.

Kodas‎: PubMed 23832487

DOI‎: 10.1002/pbc.24676

https://www.ncbi.nlm.nih.gov/pubmed/23832487 (atsiveria naujas langas)